Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $42.8100 (-4.34%) ($42.8100 - $42.8100) on Wed. Jan. 27, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.94% (three month average) | RSI | 43 | Latest Price | $42.8100(-4.34%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA declines -2.6% a day on average for past five trading days. | Weekly Trend | IOVA declines -3.9% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(48%) XBI(44%) ARKG(43%) IWO(42%) ARKK(39%) | Factors Impacting IOVA price | IOVA will decline at least -1.47% in a week (0% probabilities). VIXM(-24%) UUP(-16%) VXX(-12%) TBT(-6%) UNG(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.47% (StdDev 2.94%) | Hourly BBV | -1.8 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $36.54(-14.65%) | Inflection Point | Yes | Resistance Level | $48.13 | 5 Day Moving Average | $45.89(-6.71%) | 10 Day Moving Average | $48.1(-11%) | 20 Day Moving Average | $48.13(-11.05%) | To recent high | -17.2% | To recent low | 20.6% | Market Cap | $6.269b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |